SVRA
Price
$4.48
Change
-$0.24 (-5.08%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
TRDA
Price
$14.99
Change
+$0.06 (+0.40%)
Updated
May 17, 6:59 PM EST
80 days until earnings call
Ad is loading...

SVRA vs TRDA

Header iconSVRA vs TRDA Comparison
Open Charts SVRA vs TRDABanner chart's image
Savara
Price$4.48
Change-$0.24 (-5.08%)
Volume$516.7K
CapitalizationN/A
Entrada Therapeutics
Price$14.99
Change+$0.06 (+0.40%)
Volume$53.59K
CapitalizationN/A
View a ticker or compare two or three
SVRA vs TRDA Comparison Chart

Loading...

SVRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
SVRA vs. TRDA commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVRA is a StrongBuy and TRDA is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (SVRA: $4.48 vs. TRDA: $14.99)
Brand notoriety: SVRA and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SVRA: 99% vs. TRDA: 143%
Market capitalization -- SVRA: $619.09M vs. TRDA: $506.05M
SVRA [@Biotechnology] is valued at $619.09M. TRDA’s [@Biotechnology] market capitalization is $506.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SVRA’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • SVRA’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SVRA’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 6 bullish TA indicator(s).

  • SVRA’s TA Score: 4 bullish, 5 bearish.
  • TRDA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than SVRA.

Price Growth

SVRA (@Biotechnology) experienced а -3.76% price change this week, while TRDA (@Biotechnology) price change was +4.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

SVRA is expected to report earnings on Aug 08, 2024.

TRDA is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for SVRA with price predictions.
OPEN
A.I.dvisor published
a Summary for TRDA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SVRA($619M) has a higher market cap than TRDA($506M). TRDA YTD gains are higher at: -0.663 vs. SVRA (-4.681).
SVRATRDASVRA / TRDA
Capitalization619M506M122%
EBITDAN/AN/A-
Gain YTD-4.681-0.663706%
P/E RatioN/A21.72-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SVRATRDA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
SVRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRDADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACIPX16.310.01
+0.06%
American Century Mid Cap Value G
KCGSX18.460.01
+0.05%
Knights of Columbus Large Cap Growth S
IHSVX27.16-0.03
-0.11%
Hartford Small Company R6
GACIX46.40-0.07
-0.15%
Gabelli Small Cap Growth I
RSVIX15.47-0.04
-0.26%
RBC Small Cap Value I

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with PCVX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-5.08%
PCVX - SVRA
41%
Loosely correlated
-1.17%
FOLD - SVRA
38%
Loosely correlated
+0.74%
PLRX - SVRA
37%
Loosely correlated
-2.18%
AVXL - SVRA
37%
Loosely correlated
+1.11%
SCPH - SVRA
37%
Loosely correlated
-1.55%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with TRVI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then TRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+0.27%
TRVI - TRDA
35%
Loosely correlated
-2.46%
PCVX - TRDA
33%
Poorly correlated
-1.17%
SVRA - TRDA
32%
Poorly correlated
-5.08%
FOLD - TRDA
32%
Poorly correlated
+0.74%
OVID - TRDA
32%
Poorly correlated
-3.82%
More